Cubist Systematic Strategies, LLC Annovis Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.84 - $19.78 $139,037 - $232,276	-11,743 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$17.58 - $37.67 $206,441 - $442,358	11,743 New	11,743 $206,000
Q3 2021 Nov 15, 2021	SELL	$30.95 - $120.97 $139,522 - $545,332	-4,508 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.55 - $96.1 $97,147 - $433,218	4,508 New	4,508 $386,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $40.8M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.